Latest filing published 06 Feb 2026 for Scholar Rock Holding Corp, €9.9M.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Invus Global Management, LLC across 2 companies, led by Lexicon Pharmaceuticals, Inc. and Scholar Rock Holding Corp. In total, 5 filings cover trades dated from 11 December 2025 to 2 February 2026.
Every open-market trade on record is a purchase: 1 purchase worth €1.7M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants. In 2026 alone, the filings show 1 purchase and no sales.
On 6 February 2026 came the latest disclosure, a share grant for €9.9M in Scholar Rock Holding Corp. The clock since the last published purchase (4 February 2026) now reads 261 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations